Literature DB >> 16546685

Assembling pieces of the cardiac puzzle; calreticulin and calcium-dependent pathways in cardiac development, health, and disease.

Jeffrey M Lynch1, Kaari Chilibeck, Yuanyuan Qui, Marek Michalak.   

Abstract

Calreticulin is a Ca(2+)-binding chaperone of the sarcoplasmic/endoplasmic reticulum. It is an important Ca(2+) buffer, a regulator of Ca(2+) homeostasis, and a component of protein quality control processes in the secretory pathway. Calreticulin is essential for cardiac development; its gene is tightly regulated during cardiogenesis, and in the absence of calreticulin, cardiac development is impaired. The protein is highly expressed in the developing heart and down-regulated after birth in the healthy mature heart. Overexpression of calreticulin in postnatal heart leads to bradyarrhythima and complete heart block, followed by sudden death. The calreticulin gene is a target of transcription factors involved in fetal cardiac program (Nkx2.5, myocardin, myocyte enhancer factor 2C, and GATA6). Calreticulin works upstream of calcineurin and myocyte enhancer factor 2C in a Ca(2+)-dependent signal transduction cascade linking the endoplasmic reticulum and the nucleus during cardiac development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546685     DOI: 10.1016/j.tcm.2006.01.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  10 in total

1.  Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.

Authors:  Randolph S Faustino; Anca Chiriac; Nicolas J Niederlander; Timothy J Nelson; Atta Behfar; Prasanna K Mishra; Slobodan Macura; Marek Michalak; Andre Terzic; Carmen Perez-Terzic
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

Review 2.  Organellar calcium buffers.

Authors:  Daniel Prins; Marek Michalak
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

3.  Disrupted WNT signaling in mouse embryonic stem cells in the absence of calreticulin.

Authors:  Jody Groenendyk; Marek Michalak
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

Review 4.  Calreticulin and the Heart.

Authors:  Jody Groenendyk; Wen-An Wang; Alison Robinson; Marek Michalak
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

5.  Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression.

Authors:  Jing Liu; Deborah K Lieu; Chung Wah Siu; Ji-Dong Fu; Hung-Fat Tse; Ronald A Li
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-08       Impact factor: 4.249

6.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Authors:  Lei Song; Ronny Alcalai; Michael Arad; Cordula M Wolf; Okan Toka; David A Conner; Charles I Berul; Michael Eldar; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.

Authors:  Benben Song; Yashu Liu; Toufan Parman; Shufeng Liu; Jennifer K Miller; Xiaohua Liu; Mary J Tanga; Jon Mirsalis
Journal:  J Proteome Res       Date:  2014-11-07       Impact factor: 4.466

8.  Calreticulin expression in human cardiac myocytes induces ER stress-associated apoptosis.

Authors:  Michael W Stoner; Charles F McTiernan; Iain Scott; Janet R Manning
Journal:  Physiol Rep       Date:  2020-04

9.  Inhibition of adipogenesis: a new job for the ER Ca2+ pool.

Authors:  Jacopo Meldolesi
Journal:  J Cell Biol       Date:  2008-07-07       Impact factor: 10.539

10.  Combinatorial Treatment of Human Cardiac Engineered Tissues With Biomimetic Cues Induces Functional Maturation as Revealed by Optical Mapping of Action Potentials and Calcium Transients.

Authors:  Andy On-Tik Wong; Nicodemus Wong; Lin Geng; Maggie Zi-Ying Chow; Eugene K Lee; Hongkai Wu; Michelle Khine; Chi-Wing Kong; Kevin D Costa; Wendy Keung; Yiu-Fai Cheung; Ronald A Li
Journal:  Front Physiol       Date:  2020-03-12       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.